FMR LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$0
-100.0%
74
-92.6%
0.00%
Q4 2018$2,000
-100.0%
1,000
-99.9%
0.00%
-100.0%
Q1 2018$5,381,000
+28.8%
1,450,481
-0.0%
0.00%
Q4 2017$4,179,000
-35.8%
1,451,164
+0.0%
0.00%
-100.0%
Q3 2017$6,513,000
-11.5%
1,450,481
-9.5%
0.00%0.0%
Q2 2017$7,361,000
+21.0%
1,603,622
+11.0%
0.00%0.0%
Q1 2017$6,081,000
-3.2%
1,444,404
-5.0%
0.00%0.0%
Q4 2016$6,283,000
-76.5%
1,521,204
-53.9%
0.00%
-75.0%
Q3 2016$26,739,000
-55.5%
3,301,071
-57.2%
0.00%
-50.0%
Q2 2016$60,094,000
-3.3%
7,704,406
-4.3%
0.01%
-11.1%
Q1 2016$62,176,000
-35.0%
8,053,872
-9.2%
0.01%
-30.8%
Q4 2015$95,707,000
+56.1%
8,869,9720.0%0.01%
+44.4%
Q3 2015$61,292,000
-22.0%
8,869,9720.0%0.01%
-10.0%
Q2 2015$78,588,000
-10.1%
8,869,9720.0%0.01%
-9.1%
Q1 2015$87,458,000
-34.1%
8,869,972
-18.1%
0.01%
-35.3%
Q4 2014$132,714,000
+103.8%
10,833,816
+66.0%
0.02%
+88.9%
Q3 2014$65,115,000
+31.0%
6,524,572
-0.6%
0.01%
+28.6%
Q2 2014$49,688,000
+1606.3%
6,563,772
+641.5%
0.01%
Q1 2014$2,912,000
+147.2%
885,200
+149.4%
0.00%
Q4 2013$1,178,000
-93.6%
354,925
-94.2%
0.00%
-100.0%
Q3 2013$18,419,000
-79.9%
6,099,057
-45.6%
0.00%
-80.0%
Q2 2013$91,627,00011,201,3820.02%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders